96 related articles for article (PubMed ID: 10420168)
21. Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration.
Colado MI; O'Shea E; Granados R; Esteban B; Martín AB; Green AR
Br J Pharmacol; 1999 Feb; 126(4):911-24. PubMed ID: 10193771
[TBL] [Abstract][Full Text] [Related]
22. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
[TBL] [Abstract][Full Text] [Related]
23. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: Synaptosomal uptake and tissue concentrations.
Sabol KE; Lew R; Richards JB; Vosmer GL; Seiden LS
J Pharmacol Exp Ther; 1996 Feb; 276(2):846-54. PubMed ID: 8632358
[TBL] [Abstract][Full Text] [Related]
24. Effects of salicylate on 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats.
Yeh SY
Pharmacol Biochem Behav; 1997 Nov; 58(3):701-8. PubMed ID: 9329062
[TBL] [Abstract][Full Text] [Related]
25. Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR.
Colado MI; Granados R; O'Shea E; Esteban B; Green AR
Br J Pharmacol; 1998 Jun; 124(3):479-84. PubMed ID: 9647471
[TBL] [Abstract][Full Text] [Related]
26. Involvement of the brain serotonergic system in the locomotor stimulant effects of chlorpheniramine in Wistar rats: implication of postsynaptic 5-HT1A receptors.
Karamanakos PN; Pappas P; Marselos M
Behav Brain Res; 2004 Jan; 148(1-2):199-208. PubMed ID: 14684260
[TBL] [Abstract][Full Text] [Related]
27. Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat.
Malberg JE; Seiden LS
J Neurosci; 1998 Jul; 18(13):5086-94. PubMed ID: 9634574
[TBL] [Abstract][Full Text] [Related]
28. Protection against 3,4-methylenedioxymethamphetamine-induced neurodegeneration produced by glutathione depletion in rats is mediated by attenuation of hyperthermia.
O'Shea E; Easton N; Fry JR; Green AR; Marsden CA
J Neurochem; 2002 May; 81(4):686-95. PubMed ID: 12065628
[TBL] [Abstract][Full Text] [Related]
29. 3,4-Methylenedioxymethamphetamine increases pro-interleukin-1beta production and caspase-1 protease activity in frontal cortex, but not in hypothalamus, of Dark Agouti rats: role of interleukin-1beta in neurotoxicity.
O'Shea E; Sanchez V; Orio L; Escobedo I; Green AR; Colado MI
Neuroscience; 2005; 135(4):1095-105. PubMed ID: 16165281
[TBL] [Abstract][Full Text] [Related]
30. Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex.
Nair SG; Gudelsky GA
Brain Res Bull; 2006 Apr; 69(4):382-7. PubMed ID: 16624669
[TBL] [Abstract][Full Text] [Related]
31. Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT.
Darvesh AS; Gudelsky GA
Brain Res; 2005 Sep; 1056(2):168-75. PubMed ID: 16098955
[TBL] [Abstract][Full Text] [Related]
32. Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons.
Higuchi M; Suzuki Y; Yatani Y; Kitagawa Y; Nagayasu K; Shirakawa H; Nakagawa T; Kaneko S
J Neurochem; 2008 Sep; 106(6):2410-20. PubMed ID: 18662325
[TBL] [Abstract][Full Text] [Related]
33. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
Broening HW; Morford LL; Vorhees CV
Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503
[TBL] [Abstract][Full Text] [Related]
34. In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.
Callaghan PD; Owens WA; Javors MA; Sanchez TA; Jones DJ; Irvine RJ; Daws LC
J Neurochem; 2007 Feb; 100(3):617-27. PubMed ID: 17181558
[TBL] [Abstract][Full Text] [Related]
35. Studies on the mechanisms underlying amiloride enhancement of 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.
Goñi-Allo B; Puerta E; Hervias I; Di Palma R; Ramos M; Lasheras B; Aguirre N
Eur J Pharmacol; 2007 May; 562(3):198-207. PubMed ID: 17320075
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in rats.
Vanattou-Saïfoudine N; McNamara R; Harkin A
Br J Pharmacol; 2010 Jun; 160(4):860-77. PubMed ID: 20590585
[TBL] [Abstract][Full Text] [Related]
37. Effects of d- and dl-chlorpheniramine on serotonin and 5-hydroxyindoleacetic acid levels in the regional parts of rat brain.
Sakurai E; Yamasaki S; Hikichi N; Onodera K
Yakubutsu Seishin Kodo; 1991 Aug; 11(4):237-44. PubMed ID: 1724716
[TBL] [Abstract][Full Text] [Related]
38. Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats.
Shen EY; Ali SF; Meyer JS
Neuropharmacology; 2011 Dec; 61(8):1183-92. PubMed ID: 21763331
[TBL] [Abstract][Full Text] [Related]
39. Memantine attenuates 3,4-methylenedioxymethamphetamine-induced hyperthermia in rats.
Nisijima K; Kuboshima K; Shioda K; Yoshino T; Iwamura T; Kato S
Neurosci Lett; 2012 Dec; 531(2):198-203. PubMed ID: 23142720
[TBL] [Abstract][Full Text] [Related]
40. Influence of ketanserin on the effects of methylenedioxymethamphetamine on body temperature in the mouse.
Docherty JR; Bexis S
Auton Autacoid Pharmacol; 2013 Oct; 33(3-4):35-41. PubMed ID: 23906337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
